Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105


Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts.

Gross GJ, Baker JE, Hsu A, Wu HE, Falck JR, Nithipatikom K.

Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H2201-7. doi: 10.1152/ajpheart.00815.2009. Epub 2010 Apr 16.


Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.

Li R, Wong GT, Wong TM, Zhang Y, Xia Z, Irwin MG.

Anesth Analg. 2009 Jan;108(1):23-9. doi: 10.1213/ane.0b013e3181884ba6.


Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray.

Terashvili M, Tseng LF, Wu HE, Narayanan J, Hart LM, Falck JR, Pratt PF, Harder DR.

J Pharmacol Exp Ther. 2008 Aug;326(2):614-22. doi: 10.1124/jpet.108.136739. Epub 2008 May 20.


Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.

Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.

Neuroscience. 2005;135(1):213-25.


Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.

Gross GJ, Hsu A, Falck JR, Nithipatikom K.

J Mol Cell Cardiol. 2007 Mar;42(3):687-91. Epub 2007 Jan 10.


Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.

Gross GJ, Gauthier KM, Moore J, Falck JR, Hammock BD, Campbell WB, Nithipatikom K.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2838-44. doi: 10.1152/ajpheart.00186.2008. Epub 2008 Apr 25.


Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ opioid receptors.

Gross GJ, Hsu A, Nithipatikom K, Bobrova I, Bissessar E.

J Cardiovasc Pharmacol. 2012 Feb;59(2):194-7. doi: 10.1097/FJC.0b013e318241e8c7.


Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation.

Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Caffrey JL, Vinten-Johansen J.

Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1444-51. doi: 10.1152/ajpheart.01279.2006. Epub 2008 Jan 18.


Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.

Gross ER, Hsu AK, Gross GJ.

Anesth Analg. 2009 Nov;109(5):1395-402. doi: 10.1213/ANE.0b013e3181b92201.


Morphine postconditioning protects against reperfusion injury in the isolated rat hearts.

Chen Z, Li T, Zhang B.

J Surg Res. 2008 Apr;145(2):287-94. Epub 2007 Aug 23.


Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation.

Wong GT, Li R, Jiang LL, Irwin MG.

Acta Anaesthesiol Scand. 2010 Apr;54(4):510-8. doi: 10.1111/j.1399-6576.2009.02145.x. Epub 2009 Oct 29.


Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.

Motoki A, Merkel MJ, Packwood WH, Cao Z, Liu L, Iliff J, Alkayed NJ, Van Winkle DM.

Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2128-34. doi: 10.1152/ajpheart.00428.2008. Epub 2008 Oct 3.


Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.

Nithipatikom K, Moore JM, Isbell MA, Falck JR, Gross GJ.

Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H537-42. Epub 2006 Feb 10.


Factors mediating remote preconditioning of trauma in the rat heart: central role of the cytochrome p450 epoxygenase pathway in mediating infarct size reduction.

Gross GJ, Hsu A, Gross ER, Falck JR, Nithipatikom K.

J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):38-45. doi: 10.1177/1074248412437586. Epub 2012 Mar 9.


Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction.

Maslov LN, Lishmanov YB, Oeltgen PR, Barzakh EI, Krylatov AV, Naryzhnaya NV, Pei JM, Brown SA.

Acad Emerg Med. 2010 Nov;17(11):1239-46. doi: 10.1111/j.1553-2712.2010.00910.x.


Essential activation of PKC-delta in opioid-initiated cardioprotection.

Fryer RM, Wang Y, Hsu AK, Gross GJ.

Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1346-53.


Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.

Tsai RY, Tai YH, Tzeng JI, Cherng CH, Yeh CC, Wong CS.

Neuroscience. 2009 Dec 1;164(2):435-43. doi: 10.1016/j.neuroscience.2009.08.015. Epub 2009 Aug 12.


Supplemental Content

Support Center